Ion Daniela, Stevenson Kristen, Woo Sook-Bin, Ho Vincent T, Soiffer Robert, Antin Joseph H, Treister Nathaniel S
Oral Medicine Department, Guy's and St Thomas NHS Foundation Trust, London, UK.
Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Biol Blood Marrow Transplant. 2014 Nov;20(11):1717-21. doi: 10.1016/j.bbmt.2014.06.031. Epub 2014 Jun 27.
Acute graft-versus-host-disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (HSCT). The purpose of this study was to characterize the oral features associated with aGVHD in patients who underwent HSCT between 1995 and 2010 and developed prominent oral aGVHD. Data was collected from patient medical records and analyzed descriptively. Twenty-one cases were identified, of which 5 (24%) demonstrated only oral features; the remaining 16 had variable involvement of skin (n = 14), liver (n = 7), and gut (n = 5). The median time to onset of any sign of aGVHD was 22 days (range, 8 to 154 days), and that for onset of oral aGVHD was 35 days (range, 11 to 159 days). Sites affected by nonspecific erythema and ulcerations included buccal mucosa (19 of 21; 90%) tongue (18 of 21; 86%; dorsum in 8), labial mucosa (16 of 21; 76%), palatal mucosa (15 of 21; 71%; hard palate in 7), and floor of mouth (7 of 21; 33%). Eight cases (38%) presented with lip ulceration and crusting. In addition to systemic therapies, topical solutions of dexamethasone, tacrolimus, and morphine were used for ancillary support. Oral features of aGVHD may be the initial manifestation and include nonspecific erythema and ulcerations of keratinized and nonkeratinized mucosa and lips. Intensive topical therapies may help reduce symptoms and promote healing.
急性移植物抗宿主病(aGVHD)是异基因造血干细胞移植(HSCT)的主要并发症。本研究旨在描述1995年至2010年间接受HSCT并发生显著口腔aGVHD患者中与aGVHD相关的口腔特征。从患者病历中收集数据并进行描述性分析。共识别出21例病例,其中5例(24%)仅表现出口腔特征;其余16例皮肤(n = 14)、肝脏(n = 7)和肠道(n = 5)受累情况各异。aGVHD任何体征的中位发病时间为22天(范围8至154天),口腔aGVHD的发病时间为35天(范围11至159天)。受非特异性红斑和溃疡影响的部位包括颊黏膜(21例中的19例;90%)、舌(21例中的18例;86%;其中8例为舌背)、唇黏膜(21例中的16例;76%)、腭黏膜(21例中的15例;71%;其中7例为硬腭)和口底(21例中的7例;33%)。8例(38%)出现唇部溃疡和结痂。除全身治疗外,还使用地塞米松、他克莫司和吗啡局部溶液作为辅助支持。aGVHD的口腔特征可能是初始表现,包括角化和非角化黏膜及唇部的非特异性红斑和溃疡。强化局部治疗可能有助于减轻症状并促进愈合。